What’s the official price of Sanctura?
Sanctura (santuzumab) is a newly approved monoclonal antibody for metastatic breast cancer. Sanofi has not published a list price for the drug. The manufacturer says that pricing will be set through negotiations with payers and will vary by region and payer arrangement.
How does its cost compare to similar cancer drugs?
Oncology biologics that target HER2 or similar pathways typically cost between $4,000 and $8,000 per month in the United States and Canada. Because Sanctura’s mechanism and clinical profile resemble those of trastuzumab and pertuzumab, its expected list price is likely in this range, pending final market agreements.
Who decides the price and how do negotiations work?
Sanofi, the sponsor, proposes a base price to national health authorities, insurers, and pharmacy benefit managers. Payers evaluate the drug’s clinical benefit, budget impact, and cost‑effectiveness relative to existing therapies. In many markets, a reimbursement decision is reached through a formal appraisal process that can involve price discounts, risk‑sharing agreements, or managed‑entry schemes.
Does insurance cover Sanctura, and what about out‑of‑pocket costs?
Once a reimbursement decision is made, commercial and public insurers typically cover Sanctura, subject to the usual co‑pay or co‑insurance rules. Patients may still face out‑of‑pocket costs, especially if they use a high‑deductible plan. Coverage details can vary widely by country, insurer, and individual plan.
Are there patient assistance programs?
Sanofi offers a patient assistance program for eligible patients who cannot afford Sanctura. The program provides the drug at reduced or no cost, but eligibility criteria and application procedures must be met. Patients should contact their oncology care team or Sanofi’s patient support line for details.
What happens if the price changes over time?
Drug prices can shift after launch due to market competition, the entry of biosimilars, or updated health‑technology assessments. Sanofi may adjust the price or offer additional discounts in response to payer feedback or clinical data from post‑marketing studies.
How can patients find the most up‑to‑date pricing information?
The best source for current pricing is the payer or insurer’s formulary, the manufacturer’s website, or national drug pricing databases. Patients and clinicians can also request a price estimate from Sanofi’s sales representatives.